Neuropharmacological treatment of refractory idiopathic thrombocytopenic purpura: roles of circulating catecholamines and serotonin.
Lechin
Fuad
F
flechin@telcel.net.ve
van der Dijs
Bertha
B
Orozco
Beatriz
B
Jahn
Eduardo
E
Rodriguez
Símon
S
Baez
Scarlet
S
D000328:Adult; D001792:Blood Platelets / Q000737:chemistry / Q000166:cytology / Q000276:immunology; D002395:Catecholamines / Q000097:blood / Q000502:physiology; D002648:Child; D003891:Desipramine / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D009480:Neuropharmacology / Q000379:methods*; D011433:Propranolol / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000276:immunology / Q000628:therapy*; D016879:Salvage Therapy / Q000379:methods; D012701:Serotonin / Q000097:blood / Q000502:physiology; D018418:Th2 Cells; D014443:Tyrosine / Q000627:therapeutic use
D002395:Catecholamines; D012701:Serotonin; D014443:Tyrosine; D011433:Propranolol; D003891:Desipramine